首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Molecular Pharmacology

Molecular Pharmacology杂志,由American Society for Pharmacology and Experimental Therapeutics出版,于1965年创刊,Monthly,出版语言English,ISSN:0026-895X,E-ISSN:1521-0111。

投稿咨询
Molecular Pharmacology
Molecular Pharmacology
Molecular Pharmacology
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
4区
影响因子
3
CiteScore
5.2
期刊收录
SCI、SCIE

Molecular Pharmacology(中文译名:《分子药理学》),ISSN:0026-895X,EISSN:1521-0111,是American Society for Pharmacology and Experimental Therapeutics出版的国际性学术期刊,创刊于1965年,以Monthly形式稳定发行,2026年总发文量约111篇。该刊采用非OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3,2025年期刊CiteScore为5.2,2025年期刊自引率约3.3%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。Molecular Pharmacology长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期一般,3-6周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、Canada、Australia、England、GERMANY (FED REP GER)、Japan等为核心发文国家与地区;UNIVERSITY OF CALIFORNIA SYSTEMUNIVERSITY OF MICHIGAN SYSTEM、STATE UNIVERSITY SYSTEM OF FLORIDA、MONASH UNIVERSITY、PENNSYLVANIA COMMONWEALTH SYSTEM OF HIGHER EDUCATION (PCSHE)、PURDUE UNIVERSITY SYSTEM、UNIVERSITY OF TEXAS SYSTEM等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 169 / 356

52.7

学科:PHARMACOLOGY & PHARMACY SCIE Q2 120 / 356

66.43

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 138 / 352

60.9

学科:PHARMACOLOGY & PHARMACY SCIE Q2 132 / 353

62.75


中国学者近期发文

1
A subunit-selective negative allosteric modulator of GluN1/GluN3A glycine-activated recepto

Author:Jacobs, Leon; Nguyen, Trangkimberly T.; Mccallum, Adam; Epplin, Matt P.; Perszyk, Riley E.; Myers, Scott J.; Liu, Ken; Yang, Yanli; Van Der Westhuyzen, Aletta E.; Nocilla, Kelsey A.; Allen, James; Ullman, Elijah Z.; Liu, Ding; Du, Yufei; Yuan, Hongjie; Liotta, Dennis C.; Traynelis, Stephen F

Journal: MOLECULAR PHARMACOLOGY. 2026; Vol. 108, Issue 3, pp. -. DOI: 10.1016/j.molpha.2026.100104

2
Cepharanthine, a valuable sanative alternative for hepatocellular carcinoma through regulating Hippo-Yes-associated protein signal transductio

Author:Hu, Kejun; Zhao, Yukai; Fu, Xinyu; Li, Sai; Wu, Ting; Liu, Wangwang; Wang, Wei; Cheng, Cheng; Qiu, Huanhuan; Pan, Shumin; Lv, Qi; Xu, Guanglin

Journal: MOLECULAR PHARMACOLOGY. 2026; Vol. 108, Issue 3, pp. -. DOI: 10.1016/j.molpha.2026.100105

3
Fenofibrate promotes erucic acid metabolism by peroxisome enzyme EHHADH activation alleviating high-fat diet-induced steatotic liver diseas

Author:Jin, Ming; Zhang, Rongmi; Xin, Wenwen; Sun, Li; Fan, Xue; Lu, Qian; Zhang, Luyong; Jiang, Zhenzhou; Yu, Qinwei

Journal: MOLECULAR PHARMACOLOGY. 2025; Vol. 107, Issue 7, pp. -. DOI: 10.1016/j.molpha.2025.100047

4
Cyclovirobuxine inhibits ferroptosis to mitigate Alzheimer disease in glutamate-induced SH-SY5Y cell: the role of the liquid-liquid phase separation of FTH

Author:Wang, Fuwei; Zhou, Qiong; Chen, Zihao; Xie, Lihua; Zheng, Nan; Chen, Ziwen; Sun, Qiang; Du, Jikun; Lin, Jiantao; Li, Baohong; Li, Li

Journal: MOLECULAR PHARMACOLOGY. 2025; Vol. 107, Issue 7, pp. -. DOI: 10.1016/j.molpha.2025.100046

5
Upregulating vascular endothelial KCa2.3 channels alleviates pulmonary hypertension in mic

Author:Han, Meng-Zhuan; Wang, Yan; Sun, Ke-Xin; Zhang, Yong-Jian; Bai, Ru-Yue; Wu, Lin-Hong; Hai, Xia-Xia; Lai, Bao-Chang; Li, Jing-Jing; She, Gang; Zhang, Yi; Du, Xiao-Jun; Pang, Zheng-Da; Deng, Xiu-Ling

Journal: MOLECULAR PHARMACOLOGY. 2025; Vol. 107, Issue 7, pp. -. DOI: 10.1016/j.molpha.2025.100048

6
Extracellular ATP increases agonist potency and reduces latency at class B G protein-coupled receptor

Author:Zhu, Shuying; Yuan, Alice; Duffy, Tristan; Kim, Brandon H.; Ozawa, Takeaki; Dixon, S. Jeffrey; Chidiac, Peter

Journal: MOLECULAR PHARMACOLOGY. 2025; Vol. 107, Issue 6, pp. -. DOI: 10.1016/j.molpha.2025.100040

7
Doxorubicin-induced apoptosis is exacerbated by MG53 and associated with altered Akt signaling in H9c2 cell

Author:Xu, Bowen; Li, Hongye; Chen, Hongping; Ren, Yanxin; Li, Jun; Gong, Lei; Zhong, Lin; Yang, Jun

Journal: MOLECULAR PHARMACOLOGY. 2025; Vol. 107, Issue 5, pp. -. DOI: 10.1016/j.molpha.2025.100032

8
Evaluation of allosteric N-methyl-D-aspartate receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modelin

Author:Lotti, James S.; Jones, Jaron; Farnsworth, Jill C.; Yi, Feng; Zhao, Fabao; Menniti, Frank S.; Volkmann, Robert A.; Clausen, Rasmus P.; Hansen, Kasper B.

Journal: MOLECULAR PHARMACOLOGY. 2025; Vol. 107, Issue 1, pp. -. DOI: 10.1124/molpharm.124.000975


在线咨询

Molecular Pharmacology

国际简称:MOL PHARMACOL参考译名:分子药理学

年发文量:111 CiteScore:5.2 是否预警:否 Gold OA文章占比:26.15% 研究类文章占比:82.88%

杂志社联系方式:AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS, 9650 ROCKVILLE PIKE, BETHESDA, USA, MD, 20814-3995

Molecular Pharmacology